Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial
2020
Abstract
The Compare-Acute trial showed superiority of fractional flow reserve (FFR)-guided acute complete revascularisation compared to culprit-only treatment in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) at one year. The aim of this study was to investigate the outcome at three years, together with cost analysis of this strategy.